This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: California Institute of Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Emil Glibstrup: Innovator in Bis-Tetrahydroisoquinoline-Containing Compounds
Introduction
Emil Glibstrup is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of bis-tetrahydroisoquinoline-containing compounds. With a total of 2 patents, his work has implications for treating proliferative diseases.
Latest Patents
Glibstrup's latest patents focus on methods for preparing bis-tetrahydroisoquinoline-containing compounds, including (−)-Jorumycin, ecteinascidin 743, and saframycin A. These patents detail the methods of preparing these compounds, formulations that include them, and innovative methods for treating proliferative diseases using these compounds.
Career Highlights
Emil Glibstrup is affiliated with the California Institute of Technology, where he continues to advance research in his field. His work is characterized by a commitment to innovation and the application of chemistry to solve complex medical challenges.
Collaborations
Glibstrup has collaborated with esteemed colleagues such as Brian M Stoltz and Eric R Welin, contributing to a rich environment of research and development.
Conclusion
Emil Glibstrup's contributions to the field of chemistry and his innovative patents position him as a key figure in the development of treatments for proliferative diseases. His work exemplifies the intersection of research and practical application in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile